• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Cosmetic Conundrums

Author(s):

Zoe Diana Draelos, MD

Q. What is the difference between an azelaic acid gel and an azelaic acid cream?

Related Videos
1 KOL is featured in this series.
2 KOLs are featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
Benjamin Lockshin, MD, FAAD, is featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
1 KOL is featured in this series.
Related Content
Exploring Roflumilast Cream 0.3% for Refractory Palmoplantar Pustulosis
October 15th 2024

Exploring Roflumilast Cream 0.3% for Refractory Palmoplantar Pustulosis

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

LEO Pharma's Delgocitinib Launches for Chronic Hand Eczema in Germany
October 15th 2024

LEO Pharma's Delgocitinib Launches for Chronic Hand Eczema in Germany

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Join the Conversation: Share Your Journey as a Dermatology APP
October 15th 2024

Join the Conversation: Share Your Journey as a Dermatology APP

Vitiligo Identified as Possible Risk Factor for Cardiovascular Disease
October 14th 2024

Vitiligo Identified as Possible Risk Factor for Cardiovascular Disease

© 2024 MJH Life Sciences

All rights reserved.